chromogranin A (344-364)

09/12/2023 - "Modelling the occurrence of preeclampsia via logistic regression was improved when adding catestatin as a predictive factor. "
09/12/2023 - "The aim of this study was to investigate a potential association of maternal serum catestatin levels to the pathogenesis of preeclampsia. "
01/01/2022 - "In this study, we investigated the serum catestatin levels in pregnant women with and without preeclampsia. "
09/12/2023 - "Further investigations into the diagnostic value and possible therapeutic role of catestatin in preeclampsia are warranted."
09/12/2023 - "Decreased serum catestatin levels are associated with the presence of preeclampsia. "

01/01/2022 - "Overall, the data show that the gut microbiota may play a causal role in the development of features of intestinal inflammation and metabolic disorders, known to be associated with altered levels of catestatin and may, thus, provide a tractable target in the treatment and prevention of these disorders."
01/01/2022 - "Putative regulation of macrophage-mediated inflammation by catestatin."
09/20/2018 - "Catestatin Regulates Epithelial Cell Dynamics to Improve Intestinal Inflammation."
01/01/2017 - "Reactivation of Intestinal Inflammation Is Suppressed by Catestatin in a Murine Model of Colitis via M1 Macrophages and Not the Gut Microbiota."
11/29/2019 - "Catestatin prevents endothelial inflammation and promotes thrombus resolution in acute pulmonary embolism in mice."

01/01/2015 - "Catestatin exerts direct protective effects on rat cardiomyocytes undergoing ischemia/reperfusion by stimulating PI3K-Akt-GSK3β pathway and preserving mitochondrial membrane potential."
06/06/2021 - "Catestatin stimulates therapeutic angiogenesis in the mouse hind limb ischemia model. "
11/30/2010 - "The hearts were subjected to regional ischemia followed by reperfusion in the presence or absence of synthetic variants of human catestatin. "
11/26/2010 - "In addition to angiogenesis, catestatin increased density of arterioles/arteries and incorporation of endothelial progenitor cells in the hindlimb ischemia model, indicating induction of arteriogenesis and postnatal vasculogenesis. "
11/26/2010 - "In vivo, catestatin induced angiogenesis in the mouse cornea neovascularization assay and increased blood perfusion and number of capillaries in the hindlimb ischemia model. "

01/01/2018 - "Mice with diet-induced obesity (DIO mice) treated with chromogranin A peptide catestatin (CST) showed several positive results. "
01/01/2018 - "Catestatin Inhibits Obesity-Induced Macrophage Infiltration and Inflammation in the Liver and Suppresses Hepatic Glucose Production, Leading to Improved Insulin Sensitivity."
11/01/2019 - "In rodents, the administration of catestatin decreases hypertension, cardiac contractility, obesity, atherosclerosis, and inflammation, and it improves insulin sensitivity. "
06/06/2014 - "In the present work, infusions of Pe with the orexigenic neuropeptide orexin-A (ORX-A) or the novel anti-obesity sympathoinhibitory neuroactive peptide catestatin (CST) have been correlated to differing feeding and motor behaviors in the facultative hibernating hamster Mesocricetus auratus. "
01/01/2013 - "Finally, we will provide an up-to-date review of the roles played by two granin-derived peptides, the chromogranin A-derived peptide catestatin and the VGF-derived peptide TLQP-21, on lipolysis and obesity. "

01/01/2020 - "Catestatin improves insulin sensitivity by attenuating endoplasmic reticulum stress: In vivo and in silico validation."
01/01/2019 - "Serum catestatin concentrations were significantly negatively correlated with diastolic blood pressure (r = -0.253, P = 0.014), homeostatic model assessment of insulin resistance (r = -0.215, P = 0.037) and high sensitivity C-reactive protein (r = -0.208, P = 0.044). "
01/01/2018 - "Catestatin Inhibits Obesity-Induced Macrophage Infiltration and Inflammation in the Liver and Suppresses Hepatic Glucose Production, Leading to Improved Insulin Sensitivity."
11/01/2019 - "In rodents, the administration of catestatin decreases hypertension, cardiac contractility, obesity, atherosclerosis, and inflammation, and it improves insulin sensitivity. "
01/01/2020 - "Chromogranin A (CgA) peptide catestatin (CST: hCgA352-372 ) improves obesity-induced hepatic insulin resistance by reducing inflammation and inhibiting proinflammatory macrophage infiltration. "